Real-world clinical outcomes of treatment with casirivimab-imdevimab among patients with mild-to-moderate coronavirus disease 2019 during the Delta variant pandemic

por Suzuki, Yasuhito, Shibata, Yoko, Minemura, Hiroyuki, Nikaido, Takefumi, Tanino, Yoshinori, Fukuhara, Atsuro, Kanno, Ryuzo, Saito, Hiroyuki, Suzuki, Shuzo, Ishii, Taeko, Inokoshi, Yayoi, Sando, Eiichiro, Sakuma, Hirofumi, Kobayashi, Tatsuho, Kume, Hiroaki, Kamimoto, Masahiro, Aoki, Hideko, Takama, Akira, Kamiyama, Takamichi, Nakayama, Masaru, Saito, Kiyoshi, Tanigawa, Koichi, Sato, Masahiko, Kanbe, Toshiyuki, Kanzaki, Norio, Azuma, Teruhisa, Sakamoto, Keiji, Nakamura, Yuichi, Ohtani, Hiroshi, Waragai, Mitsuru, Maeda, Shinsaku, Ishida, Tokiya, Sugino, Keishi, Tsukada, Yasuhiko, Yamada, Ryuki, Sato, Riko, Onuma, Takumi, Tomita, Hikaru, Saito, Mikako, Watanabe, Natsumi, Rikimaru, Mami, Kawamata, Takaya, Umeda, Takashi, Morimoto, Julia, Togawa, Ryuichi, Sato, Yuki, Saito, Junpei, Kanazawa, Kenya, Iseki, Ken
Publicado 2022

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic

por Suzuki, Yasuhito, Shibata, Yoko, Minemura, Hiroyuki, Nikaido, Takefumi, Tanino, Yoshinori, Fukuhara, Atsuro, Kanno, Ryuzo, Saito, Hiroyuki, Suzuki, Shuzo, Inokoshi, Yayoi, Sando, Eiichiro, Sakuma, Hirofumi, Kobayashi, Tatsuho, Kume, Hiroaki, Kamimoto, Masahiro, Aoki, Hideko, Takama, Akira, Iizuka, Taku, Kamiyama, Takamichi, Nakayama, Masaru, Saito, Kiyoshi, Tanigawa, Koichi, Sato, Masahiko, Waragai, Yuichi, Kambe, Toshiyuki, Kanzaki, Norio, Azuma, Teruhisa, Okamoto, Hiromasa, Sakamoto, Keiji, Nakamura, Yuichi, Ohtani, Hiroshi, Waragai, Mitsuru, Maeda, Shinsaku, Ishida, Tokiya, Sugino, Keishi, Abe, Wataru, Tsukada, Yasuhiko, Lee, Tomoyoshi, Yamada, Ryuki, Sato, Riko, Onuma, Takumi, Tomita, Hikaru, Saito, Mikako, Watanabe, Natsumi, Rikimaru, Mami, Kawamata, Takaya, Morimoto, Julia, Togawa, Ryuichi, Sato, Yuki, Saito, Junpei, Kanazawa, Kenya, Hamaguchi, Sugihiro, Iseki, Ken
Publicado 2022

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-1...

por Shibata, Yoko, Omae, Kenji, Minemura, Hiroyuki, Suzuki, Yasuhito, Nikaido, Takefumi, Tanino, Yoshinori, Fukuhara, Atsuro, Kanno, Ryuzo, Saito, Hiroyuki, Suzuki, Shuzo, Ishii, Taeko, Inokoshi, Yayoi, Sando, Eiichiro, Sakuma, Hirofumi, Kobayashi, Tatsuho, Kume, Hiroaki, Kamimoto, Masahiro, Aoki, Hideko, Takama, Akira, Kamiyama, Takamichi, Nakayama, Masaru, Saito, Kiyoshi, Tanigawa, Koichi, Sato, Masahiko, Kambe, Toshiyuki, Kanzaki, Norio, Azuma, Teruhisa, Sakamoto, Keiji, Nakamura, Yuichi, Ohtani, Hiroshi, Waragai, Mitsuru, Maeda, Shinsaku, Ishida, Tokiya, Sugino, Keishi, Inage, Minoru, Hirama, Noriyuki, Furuyama, Kodai, Fukushima, Shigeyuki, Saito, Hiroshi, Machiya, Jun-ichi, Machida, Hiroyoshi, Abe, Koya, Iwabuchi, Katsuyoshi, Katagiri, Yuji, Aida, Yasuko, Abe, Yuki, Ota, Takahito, Ishizawa, Yuki, Tsukada, Yasuhiko, Yamada, Ryuki, Sato, Riko, Onuma, Takumi, Tomita, Hikaru, Saito, Mikako, Watanabe, Natsumi, Rikimaru, Mami, Kawamata, Takaya, Umeda, Takashi, Morimoto, Julia, Togawa, Ryuichi, Sato, Yuki, Saito, Junpei, Kanazawa, Kenya, Kurita, Noriaki, Iseki, Ken
Publicado 2023